ISIN | CH1238288042 |
---|---|
Valor Number | 123828804 |
Bloomberg Global ID | |
Fund Name | SYNCHRONY MARKET FUNDS - Synchrony Swiss Equity I |
Fund Provider |
Banque Cantonale de Genève
Genève, Switzerland Phone: +41 58 211 21 11 E-Mail: info@bcge.ch Web: www.bcge.ch |
Fund Provider | Banque Cantonale de Genève |
Representative in Switzerland | |
Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The objective of the Synchrony Swiss Equity Subfund is long term capital growth by investing in shares of the Swiss companies that make up the SPI® index. Companies are identified and selected based on their fundamentals, using a systematic stock-picking methodology. The Subfund invests at least two-thirds of its assets in shares and other securities or participation rights of companies domiciled or having a predominant amount of their business activity in Switzerland, and which are part of the SPI® index. |
Peculiarities |
Current Price * | 106.02 CHF | 13.05.2025 |
---|---|---|
Previous Price * | 106.10 CHF | 12.05.2025 |
52 Week High * | 110.33 CHF | 03.03.2025 |
52 Week Low * | 92.26 CHF | 09.04.2025 |
NAV * | 106.02 CHF | 13.05.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 204,287,559 | |
Unit/Share Assets *** | 101,997,710 | |
Trading Information SIX |
YTD Performance | +5.96% |
31.12.2024 - 13.05.2025
31.12.2024 13.05.2025 |
---|---|---|
1 month | +8.59% |
14.04.2025 - 13.05.2025
14.04.2025 13.05.2025 |
3 months | -3.62% |
13.02.2025 - 13.05.2025
13.02.2025 13.05.2025 |
6 months | +5.13% |
13.11.2024 - 13.05.2025
13.11.2024 13.05.2025 |
1 year | +2.97% |
13.05.2024 - 13.05.2025
13.05.2024 13.05.2025 |
2 years | +10.07% |
14.02.2024 - 13.05.2025
14.02.2024 13.05.2025 |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 10.38% | |
---|---|---|
Roche Holding AG | 10.06% | |
Novartis AG Registered Shares | 9.40% | |
UBS Group AG | 6.66% | |
ABB Ltd | 5.93% | |
Zurich Insurance Group AG | 4.94% | |
Compagnie Financiere Richemont SA Class A | 4.23% | |
Lonza Group Ltd | 3.65% | |
Sika AG | 3.47% | |
Alcon Inc | 3.30% | |
Last data update | 31.01.2025 |
TER | 0.61% |
---|---|
TER date | 15.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.75% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |